International Conference on Cancer Health Disparities

国际癌症健康差异会议

基本信息

项目摘要

The University of Texas Rio Grande Valley (UTRGV) is located at the United States (US)-Mexico border, a region where more than 91% of the population is Latino/Hispanic. The four counties of the Rio Grande Valley (RGV) account for almost 1.4 million people, many of whom suffer from several different health disparities including obesity, diabetes, and cancer. The School of Medicine (SOM) was founded in 2015 to provide improved health care, medical education, and biomedical research. UTRGV-SOM is strategically positioned to improve the lives and well-being of RGV surrounding communities through innovative research and patient-centered care. UTRGV-SOM attracts and supports research that will help to address the health disparities of the RGV Latino/Hispanic population. As a part of its mission to educate a diverse group of medical students, residents, and future biomedical scientists in cancer and understand cancer disparities at a global level, the first International Conference on Cancer Health Disparities (ICCHD) was held on August 13-14, 2021, in Harlingen, TX, USA. This two-day ICCHD-2021 was organized by the UTRGV-SOM with the support of R13 CA254453. About 200 national and international delegates from 10 countries attended this hybrid meeting in person and through online digital methods. Considering enthusiastic participation from US and Mexico border institutions and international participation, we propose continuation of this International Conference Series. This conference series will be expanded to take advantage of the opportunity for continued medical education for our diverse populations and to continue emphasis on minority health and cancer health disparities in US-Mexico border areas. This conference complements well the mission of the AACR Annual and AACR cancer health disparity meetings. Therefore, UTRGV-SOM respectfully requests R13 support from the NIH NCI for an Annual Research Symposium Series entitled “International Conference on Cancer Health Disparities,” to be held from December 9-10, 2022; December 8-9, 2023; December 7-8, 2024, in the RGV area. The event delegates will be representatives from NIH (NCI/NIMHD), CPRIT, and the City of Harlingen, Edinburg, McAllen, Mission, Texas, in addition to clinicians, faculty, researchers, scientists, bioinformaticians, bioethicists, and others. This International Conference also closely aligns with the mission of the NCI (NCI Global Health Center) and NIMHD, that is, to support global cancer research and cancer health disparity research to advance scientific knowledge and help all people live longer and maintain a high-quality lifestyle. The prime objectives of ICCHD will be 1) To provide a unique platform for scientific discussions between basic, clinical, and translational cancer researchers from institutions on both sides of the US-Mexico border and from other international institutions, 2) To introduce health disparities concepts and educate investigators in global cancer health disparity research and organize community-based participatory research and outreach, and 3) To enable interprofessional and transdisciplinary partnerships to bring awareness to and help eliminate minority health disparities in the U.S. and other countries.
德克萨斯大学格兰德谷分校(UTRGV)位于美国-墨西哥边境地区

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Subhash C. Chauhan其他文献

Dietary mung bean as promising food for human health: gut microbiota modulation and insight into factors, regulation, mechanisms and therapeutics—an update
  • DOI:
    10.1007/s10068-023-01495-8
  • 发表时间:
    2024-01-17
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Nirmala Sehrawat;Mukesh Yadav;Anil Kumar Sharma;Varruchi Sharma;Deepak Chandran;Sandip Chakraborty;Abhijit Dey;Subhash C. Chauhan;Kuldeep Dhama
  • 通讯作者:
    Kuldeep Dhama
Structural insights into small-molecule KRAS inhibitors for targeting KRAS mutant cancers
针对 KRAS 突变型癌症的小分子 KRAS 抑制剂的结构见解
  • DOI:
    10.1016/j.ejmech.2024.116771
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
    5.900
  • 作者:
    Divya Pandey;Subhash C. Chauhan;Vivek K. Kashyap;Kuldeep K. Roy
  • 通讯作者:
    Kuldeep K. Roy
Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy
  • DOI:
    10.1186/s13048-024-01485-2
  • 发表时间:
    2024-08-08
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Shabnam Malik;Mohammed Sikander;Natasha Bell;Daniel Zubieta;Maria C. Bell;Murali M. Yallapu;Subhash C. Chauhan
  • 通讯作者:
    Subhash C. Chauhan
Protein subunit vaccines: Promising frontiers against COVID-19
蛋白质亚单位疫苗:对抗 COVID-19 的有希望的前沿领域
  • DOI:
    10.1016/j.jconrel.2024.01.017
  • 发表时间:
    2024-02-01
  • 期刊:
  • 影响因子:
    11.500
  • 作者:
    Vivek P. Chavda;Eswara Naga Hanuma Kumar Ghali;Pankti C. Balar;Subhash C. Chauhan;Nikita Tiwari;Somanshi Shukla;Mansi Athalye;Vandana Patravale;Vasso Apostolopoulos;Murali M. Yallapu
  • 通讯作者:
    Murali M. Yallapu
Bioactive compounds from high altitude lake <em>Arthrospira platensis</em> HANL01: Antioxidant property, thermal stability and antibacterial assessment against multiple antibiotics resistant bacteria
  • DOI:
    10.1016/j.biteb.2023.101398
  • 发表时间:
    2023-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ritu Chauhan;Ashutosh Tripathi;Abhishek Chauhan;Rupesh Kumar Basniwal;Anuj Ranjan;Arpna Kumari;Vishnu D. Rajput;Evgeniya V. Prazdnova;Tatiana Minkina;Subhash C. Chauhan;Tanu Jindal;Ram Prasad
  • 通讯作者:
    Ram Prasad

Subhash C. Chauhan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Subhash C. Chauhan', 18)}}的其他基金

MUC13 Mucin in Colerectal Cancer Health Disparity
MUC13 粘蛋白在结肠直肠癌健康差异中的作用
  • 批准号:
    10016192
  • 财政年份:
    2019
  • 资助金额:
    $ 2.5万
  • 项目类别:
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
胰腺癌靶向纳米技术平台的开发
  • 批准号:
    9318460
  • 财政年份:
    2016
  • 资助金额:
    $ 2.5万
  • 项目类别:
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
胰腺癌靶向纳米技术平台的开发
  • 批准号:
    9931148
  • 财政年份:
    2016
  • 资助金额:
    $ 2.5万
  • 项目类别:
Targeted Nanotherapy for Pancreatic Cancer
胰腺癌靶向纳米治疗
  • 批准号:
    9934149
  • 财政年份:
    2016
  • 资助金额:
    $ 2.5万
  • 项目类别:
Targeted Nanotherapy for Pancreatic Cancer
胰腺癌靶向纳米治疗
  • 批准号:
    9186665
  • 财政年份:
    2016
  • 资助金额:
    $ 2.5万
  • 项目类别:
MUC13 Mucin in Colorectal Cancer Health Disparity
MUC13 粘蛋白在结直肠癌健康差异中的作用
  • 批准号:
    9313845
  • 财政年份:
    2016
  • 资助金额:
    $ 2.5万
  • 项目类别:
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
胰腺癌靶向纳米技术平台的开发
  • 批准号:
    9188609
  • 财政年份:
    2016
  • 资助金额:
    $ 2.5万
  • 项目类别:
Etiology of cervical cancer health disparity in American Indian women
美洲印第安女性宫颈癌健康差异的病因学
  • 批准号:
    8287944
  • 财政年份:
    2012
  • 资助金额:
    $ 2.5万
  • 项目类别:
Etiology of cervical cancer health disparity in American Indian women
美洲印第安女性宫颈癌健康差异的病因学
  • 批准号:
    8737805
  • 财政年份:
    2012
  • 资助金额:
    $ 2.5万
  • 项目类别:
Etiology of cervical cancer health disparity in American Indian women
美洲印第安女性宫颈癌健康差异的病因学
  • 批准号:
    8495289
  • 财政年份:
    2012
  • 资助金额:
    $ 2.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了